Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Viridian Therapeutics (VRDN)

Logo grafis Viridian Corp (VRDN)

Optimizing external research outsourcing stabilizes the growth rate of quarterly earnings per share, where -110.60 represents the latest level. An efficient antibody pipeline reduces long-term risks, impacting cash flow. A narrow profile in treating rare eye pathologies guarantees multi-year monetization of discoveries. The price action of the curve helps investors avoid information gaps between Viridian Therapeutics (VRDN) financial reports.

VRDN: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan viridiantherapeutics.com 04.07.2022 - 16.11.2026

Viridian Therapeutics (VRDN) - rincian metrik lan laporan keuangan

Analisis kabeh metrik perusahaan:Viridian Therapeutics - VRDN
Produk asil prodhuksi Viridian Corp

The indicator tracks the daily dynamics of quarterly net earnings per share growth, smoothing out the time gaps between reports. By analyzing the quarterly change in EPS, an investor determines the strength of the fundamental momentum and avoids overpaying for the asset. Growth in this metric confirms the effectiveness of capital management. For Viridian Therapeutics (VRDN), this reflects the successful preparation of production sites. Scaling the output of ophthalmological antibodies should ensure long-term financial growth.

Pesaing wigati

Alcon Corp (ALC) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Bausch Health (BLCO)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan glaukos.com|Apellis Pharmaceuticals (APLS) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BLTE|OCUL - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan HROW (Harrow Inc)|LENZ Corp (LENZ) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|OCS: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan eyepointpharma.com|KOD: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Aldeyra Therapeutics (ALDX)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan KALA|IRD - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan okyopharma.com (OKYO)|Wutah bathi EPS kuartalan Adverum Biotechnologies Inc. (ADVM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan outlooktherapeutics.com OTLK|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Clearside Biomedical, Inc. (CLSD)|NBY - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Eyenovia Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|GHSI (Guardion Health Sciences) - Wutah bathi EPS kuartalan|Ocuphire Pharma - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OPT (Opthea)